Drug Licensing

Balaji said it had tested its PG using US and Indian pharma standards at the behest of its non-pharma clients, and this was the reason why those standards were mentioned in its PG labels

The agreement gives Glenmark exclusive rights to develop and commercialise cancer drug Trastuzumab Rezetecan outside China, the US, Europe, and other select markets

The Supreme Court had earlier said that IMA needs to 'put its house in order'

Ichnos is set to receive $320 million upfront for development, regulatory and sales payments, coupled with low double-digit royalties

Had the recognition not come, then students from several colleges may have found it difficult to appear for the USMLE if their college was not recognised by the WFME

Proposals aim to standardise drug manufacturing practices after a few Indian medicines were flagged as 'substandard' by the WHO

U.S. health officials have granted emergency authorisation to a third antibody drug to help reduce hospitalisations and deaths due to Covid-19

The companies have expanded their collaboration and license agreement

Price hike likely to arrest the number of bogus drug registrations

At present, the renewal of licences for each formulation rests with state regulators and is around 3 years